Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

392 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

NCT02953938

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +9 more
Locations
  • Novartis Investigative Site Nagakute, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kita-gun, Kagawa-ken, Japan
  • Novartis Investigative Site Tsu, Mie-ken, Japan
View Trial Details
Completed

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

NCT03295877

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • California Retina Consultants Bakersfield, California, United States
  • Northern California Retina Vitreous Associates Mountain View, California, United States
  • Retinal Consultants Med Group Sacramento, California, United States
  • California Retina Consultants Santa Barbara, California, United States
View all 13 locations
View Trial Details
Completed

A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies

NCT01977846

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
Locations
  • Greater Baltimore Medical Center Baltimore, Maryland, United States
  • Wilmer Eye Institute, Johns Hopkins University Baltimore, Maryland, United States
  • Cole Eye Institute, Cleveland Clinic Cleveland, Ohio, United States
  • Scheie Eye Institute, University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

NCT02288559

Conditions
Eye Diseases, Geographic Atrophy, Macular Degeneration, +2 more
Locations
  • Barnet Dulaney Perkins Eye Center Mesa, Arizona, United States
  • University of Arizona; Banner University Medical, Department of Opthalmology Tucson, Arizona, United States
  • Northwest Arkansas Retina Associates Springdale, Arkansas, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 36 locations
View Trial Details
Completed

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

NCT01908816

Conditions
Cardiovascular Diseases, Choroid Diseases, Choroidal Neovascularization, +19 more
Locations
  • Novartis Investigative Site Bobigny, Seine Saint Denis, France
  • Novartis Investigative Site Amiens, France
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Bordeaux, France
View all 39 locations
View Trial Details

Related conditions